136 J. Am. Chem. Soc., Vol. 119, No. 1, 1997
Denmark and Thorarensen
0.29 (s, 3H), 0.23 (s, 3H); 13C NMR (100 MHz, CDCl3) 177.27, 137.86,
133.56, 129.24, 127.88, 98.81, 84.48, 71.83, 67.91, 51.80, 45.30, 30.39,
-3.34, -3.41; IR (KBr) 3543 (w), 1732 (s); MS (CI, CH4) 348 (14),
320 (M+ + H, 31); [R]25D -116.5° (CHCl3, c ) 0.60); TLC Rf ) 0.36
(CHCl3/MeOH, 9/1); HPLC (Column Daicel, Chiralpak AD amylose
tris(3,5-dimethylphenylcarbamate) (25 cm × 4.6 mm); method hexane/
EtOH, 90/10, 0.9 mL/min) tR (1S,5aR,5R,7aS,7bR) 18.1 min (97.4%),
tR (1R,5aS,5S,7aR,7bS) 27.2 min (2.5%). Anal. Calcd for C16H21NO4-
Si (319.42): C, 60.16%; H, 6.62%; N, 4.38%. Found: C, 59.99%; H,
6.77%; N, 4.30%. 37: 1H NMR (400 MHz, CDCl3) 9.04 (s, 1H), 7.55-
7.28 (m, 5H), 6.74 (t, J ) 1.8, 1H), 6.02 (t, J ) 1.9, 1H), 4.95 (septet,
J ) 6.2, 1H), 4.59 (d, J ) 2.7, 1H), 3.98 (d, J ) 6.3, 2H), 3.42 (dt, Jd
) 2.8, Jt ) 6.4, 2H), 1.20 (d, J ) 6.4, 3H), 1.09 (d, J ) 6.1 3H), 0.42
(s, 3H), 0.42 (s, 3H); 13C NMR (100 MHz, CDCl3) 173.07, 140.05,
133.84, 128.57, 128.28, 127.49, 124.87, 114.26, 113.31, 71.66, 70.06,
64.17, 43.38, 21.63, -1.51, -1.58; IR (CDCl3) 3608 (w), 3520 (w),
1725 (s); MS (70 eV) 378 (M+ + H, 2); HRMS calcd for (C19H28-
NO5Si) 378.172095, found 378.173677. 38: 1H NMR (400 MHz,
CDCl3) 8.67 (s, 1H), 7.56-7.53 (m, 2H), 7.36-7.32 (m, 3H), 6.83
(dd, J ) 1.5, 2.2, 1H), 6.03 (m, 1H), 4.66 (dd, J ) 8.2, 8.9, 1H), 4.39
(d, J ) 10.9, 1H), 4.34 (dd, J ) 9.0, 11.0, 1H), 3.71 (dddd, J ) 0.7,
8.1, 11.0, 11.0, 1H), 0.46 (s, 6H); MS (70 eV) 318 (M+ + H, 1).
(4/1, 2/1, 1/1, 1/2, 0/1) to afford 505 mg (95%) of (+)-33 as a 11/1
mixture of methyl anomers as determined by 1H NMR. An analytical
sample was prepared by high-vacuum, bulb-to-bulb distillation. (+)-
33: bp 250 °C (4.8 × 10-5 mmHg); 1H NMR (400 MHz, CDCl3) 7.55-
7.53 (m, 2H), 7.38-7.34 (m, 3H), 5.56 (d, J ) 8.5, 1H), 5.16 (s, 1H),
4.61 (t, J ) 3.5, 1H), 4.10 (dd, J ) 3.0, 5.6, 1H), 4.88 (dd, J ) 8.4,
11.6, 1H), 3.32 (s, 3H), 3.28 (s, 3H), 3.24-3.18 (m, 2H), 1.85 (ddd, J
) 4.1, 8.2, 10.6, 1H), 0.42 (s, 3H), 0.37 (s, 3H); 13C NMR (100 MHz,
CDCl3) 170.85, 137.50, 133.56, 129.32, 127.86, 105.21, 84.30, 78.11,
67.17, 54.64, 50.12, 45.74, 39.98, 30.10, -3.31, -3.50; IR (CHCl3)
1721 (s); MS (CI, CH4) 414 (11), 413 (25), 412 (M+ + H, 100); [R]25
D
+134.1° (CHCl3, c ) 0.57); TLC Rf ) 0.77 (CHCl3/MeOH, 9/1). Anal.
Calcd for C18H25NO6SiS (411.54): C, 52.53%; H, 6.12%; N, 3.40%.
Found: C, 52.38%; H, 6.16%; N, 3.30%.
(1R,5aS,5R,7aR,7bR)-5-Hydroxy-1-(methanesulfonyloxy)-7-meth-
oxy-6-oxaoctahydro-2H-cyclopenta[gh]pyrrolizin-2-one ((+)-34). A
solution of (+)-33 (0.501 g, 1.217 mmol), potassium bromide (0.173
g, 1.46 mmol, 1.2 equiv), and sodium acetate (1.23 g, 15.0 mmol, 12.4
equiv) in acetic acid (2.9 mL) was cooled to 0 °C. Peracetic acid (8.9
mL, 36% v/v) was added dropwise at a rate to maintain the reaction
temperature below rt (ca. 20 min). Gas evolution was observed during
the addition of the peracetic acid. The resulting solution was stirred
at rt for 3 h then was cooled to 0 °C. The reaction mixture was
quenched by adding a catalytic amount of 5% Pd/C, and the resulting
black suspension was stirred at 0 °C for 30 min and then was directly
purified by silica gel chromatography eluting with CHCl3/MeOH (1/0,
19/1, 9/1). (Note: extreme care should be taken handling the peracetic
acid residue during the silica gel chromatography, since a Violent
exothermic reaction can take place if the reaction is not quenched
properly.) The crude product was repurified by silica gel chromatog-
raphy eluting with CHCl3/MeOH (1/0, 19/1, 9/1) to afford 291 mg
(81%) of (+)-34. An analytical sample was obtained by recrystalli-
zation from acetone/Et2O/pentane. (+)-34: mp (sealed tube) 145 °C
(1R,5aS,5R,7R,7aR,7bR) and (1R,5aS,5R,7S,7aR,7bR)-1-Hydroxy-
7-methoxy-6-oxa-5-(dimethylphenylsilyl)octahydro-2H-cyclopenta-
[gh]pyrrolizin-2-one (32). To a solution of (+)-31 (0.445 g, 1.39
mmol) and p-toluenesulfonic acid (0.072 g, 0.422 mmol, 0.30 equiv)
in MeOH (85 mL) was added trimethyl orthoformate (3.3 mL). The
resulting solution was stirred at rt for 13 h and was quenched with
poly(vinylpyridine) (0.089 g). The suspension was filtered, and the
filtrate was concentrated in vacuo. The resulting crude product was
purified by basic alumina (activity II) column chromatography eluting
with CHCl3/MeOH (1/1, 6/1, 4/1, 2/1) to afford 0.439 g (95%) of 32
(mixture of methyl acetal anomer) as a light brown oil. The composi-
1
1
dec (acetone/Et2O/pentane); H NMR (400 MHz, CD3OD) 5.72 (d, J
tion of 32 was determined by H NMR to be an 6.0/1 mixture of 7R/
) 8.0, 1H), 5.24 (s, 1H), 4.66 (dt, Jd ) 4.0, Jt ) 7.3, 1H), 4.44 (dd, J
) 2.8, 4.0, 1H), 4.36 (dd, J ) 2.7, 5.3, 1H), 3.43 (d, J ) 7.6, 2H),
3.36 (s, 3H), 3.27 (s, 3H), 3.28-3.23 (m, 1H); 13C NMR (100 MHz,
CD3OD) 172.84, 107.48, 83.34, 78.25, 73.35, 67.00, 55.53, 52.75, 50.63,
7â anomers. For analytical purposes the anomers were separated by
silica gel chromatography eluting with hexane/EtOAc (2/1, 1/1, 1/2,
1/4, 0/1, then CHCl3/MeOH 4/1) followed by high-vacuum bulb-to-
1
bulb distillation. (+)-32a: (7R) bp 195 °C (5 × 10-5 mmHg); H
39.00; IR (KBr) 1692 (s); MS (CI, CH4) 294 (M+ + H, 24); [R]23
NMR (400 MHz, CDCl3) 7.56-7.54 (m, 2H), 7.37-7.39 (m, 3H), 5.24
(s, 1H), 4.70 (d, J ) 8.3, 1H), 4.58 (t, J ) 3.5, 1H), 4.08 (dd, J ) 2.9,
5.4, 1H), 3.88 (dd, J ) 8.4, 11.6, 1H), 3.51 (s, 1H), 3.28 (s, 3H), 3.21-
3.15 (m, 1H), 3.10 (dd, J ) 5.4, 8.3, 1H), 1.83 (ddd, J ) 4.1, 8.3,
10.6, 1H), 0.41 (s, 3H), 0.36 (s, 3H); 13C NMR (100 MHz, CDCl3)
177.62, 137.86, 133.59, 129.19, 127.79, 105.12, 84.01, 71.65, 67.59,
54.60, 51.01, 45.26, 30.25, -3.32, -3.47; IR (CHCl3) 3528 (w), 1702
(s); MS (CI, CH4) 362 (17), 334 (M+ + H, 33); [R]25D +172.2° (CHCl3,
c ) 0.73); TLC Rf ) 0.56 (CHCl3/MeOH, 9/1), Rf ) 0.33 (EtOAc).
Anal. Calcd for C17H23NO4Si (333.45): C, 61.23%; H, 6.95%; N,
4.20%. Found: C, 61.07%; H, 7.07%; N, 4.18%. (-)-32b: (7â) bp
D
+93.9° (MeOH, c ) 0.46); TLC Rf ) 0.39 (CHCl3/MeOH, 9/1). Anal.
Calcd for C10H15NO7S (293.29): C, 40.95%; H, 5.15%; N, 4.77%.
Found: C, 40.76%; H, 5.21%; N, 4.94%.
(1R,5aS,5R,7S,7aR,7bR)-5-Dihydroxy-1-(methanesulfonyloxy)-6-
oxaoctahydro-2H-cyclopenta[gh]pyrrolizin-2-one ((+)-35). A solu-
tion of (+)-34 (0.304 g, 1.036 mmol) in 90% aqueous trifluoroacetic
acid (TFA) (25 mL) was stirred at 60 °C for 24 h. The solution was
then repeatedly diluted with benzene (3 × 30 mL) and concentrated in
vacuo. The crude product was then purified by silica gel column
chromatography eluting with hexane/EtOAc (2/1, 1/1, then acetone)
and repurified by silica gel chromatography eluting with hexane/EtOAc
(2/1, 1/1, then CHCl3/MeOH 9/1, then acetone) to afford 0.218 g (75%)
1
195 °C (3 × 10-5 mmHg); H NMR (400 MHz, CDCl3) 7.55-7.52
(m, 2H), 7.37-7.34 (m, 3H), 5.12 (d, J ) 6.2, 1H), 4.73 (dd, J ) 6.1,
11.3, 1H), 4.61 (t, J ) 3.7, 1H), 3.99 (dd, J ) 3.8, 4.8, 1H), 3.93 (d,
J ) 11.7, 1H), 3.71 (t, J ) 10.8, 1H), 3.39-3.31 (m, 1H), 3.34 (s,
3H), 3.29-3.25 (m, 1H), 1.81 (dt, Jd ) 3.8, Jt ) 10.2, 1H), 0.43 (s,
3H), 0.39 (s, 3H); 13C NMR (100 MHz, CDCl3) 177.22, 137.42, 133.57,
129.32, 127.91, 108.85, 85.27, 75.24, 66.61, 57.33, 49.37, 45.98, 33.40,
-3.43, -3.46; IR (CHCl3) 1713 (s); MS (CI, CH4) 363 (10), 362 (39),
1
of (+)-35. (+)-35: mp 101-106 °C (EtO2/MeOH); H NMR (400
MHz, CD3OD) 5.73 (d, J ) 7.8, 1H), 5.66 (s, 1H), 4.64 (ddd, J ) 4.3,
6.6, 7.7, 1H), 4.57 (dd, J ) 3.0, 4.2, 1H), 4.37 (dd, J ) 2.9, 5.4, 1H).
3.43-3.40 (m, 2H), 3.27 (s, 3H), 3.22 (ddd, J ) 1.2, 7.8, 5.3, 1H); 13
C
NMR (100 MHz, CD3OD) 172.90, 100.74, 83.03, 78.62, 73.35, 67.20,
53.49, 50.71, 38.99; IR (KBr) 3450 (s, br), 1715 (s); MS (CI, CH4)
280 (M+ + H, 12); HRMS calcd for (C9H14NO7S) 280.049 099, found
280.048 001; [R]23D +67.5° (MeOH, c ) 0.58); TLC Rf ) 0.19 (CHCl3/
MeOH, 9/1).
(1S,2R,6R,7S,7aR)-7-(Hydroxymethyl)-6-(methanesulfonyloxy)-
4-(trihydridoboryl)hexahydro-1H-pyrrolizine-1,2-diol (36). To a
solution of lactol (+)-35 (20 mg, 0.0716 mmol) in THF (20 mL) was
added BH3 (1.0 M in THF, 2.86 mL, 2.86 mmol, 40 equiv). Gas
evolution was observed, and the resulting solution was heated to 72
°C (external 80 °C) for 4 h, whence a white precipitate formed. The
mixture was cooled to rt and concentrated in vacuo. The residual oil
was redissolved in MeOH (2 × 10 mL) and concentrated in vacuo to
afford 23 mg of 36. The crude product was purified by silica gel
chromatography eluting with CHCl3/MeOH (1/0, 19/1, 9/1, 6/1, 4/1)
to give 15.2 mg (75%) of 36. 36: 1H NMR (400 MHz, CD3OD) 5.31
(ddd, J ) 4.4, 6.9, 7.8, 1H), 4.39 (ddd, J ) 3.7, 7.8, 9.7, 1H), 4.12-
334 (M+ + H, 17); [R]23 -21.0° (CHCl3, c ) 0.32); TLC Rf ) 0.59
D
(CHCl3/MeOH, 9/1), Rf ) 0.14 (EtOAc). Anal. Calcd for C17H23-
NO4Si (333.45): C, 61.23%; H, 6.95%; N, 4.20%. Found: C, 61.38%;
H, 7.01%; N, 4.32%.
(1R,5aS,5R,7aR,7bR)-5-(Dimethylphenylsilyl)-1-(methane-
sulfonyloxy)-7-methoxy-6-oxooctahydro-2H-cyclopenta[gh]pyrrolizin-
2-one ((+)-33). To a solution of methyl acetal 32 (433 mg, 1.29 mmol)
in CH2Cl2 (36 mL) was added methanesulfonyl chloride (0.20 mL, 2.59
mmol, 2.0 equiv) and triethylamine (0.36 mL, 2.59 mmol, 2.0 equiv)
at rt. The resulting solution was stirred for 1.5 h and then was diluted
with CH2Cl2 (100 mL) and washed with saturated aqueous CuSO4
solution (50 mL) and brine (50 mL). The aqueous layers were back-
extracted with CH2Cl2 (50 mL), and the combined organic extracts were
dried (Na2SO4), filtered, and concentrated in vacuo. The crude product
was purified by silica gel chromatography eluting with hexane/EtOAc